St. Louis, MO, United States of America

Mark A Fitzgerald

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 11.5

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • St. Louis, MO (US) (2023)
  • Cambridge, MA (US) (2021 - 2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Mark A Fitzgerald: Innovator in Pharmaceutical Chemistry

Introduction

Mark A Fitzgerald is a prominent inventor based in St. Louis, MO, known for his significant contributions to pharmaceutical chemistry. With a total of 10 patents to his name, Fitzgerald has made remarkable advancements in the field of macrocyclic indole derivatives, which have potential applications in treating various diseases.

Latest Patents

Fitzgerald's latest patents include "Macrocyclic Fluorine Substituted Indole Derivatives" and "Substituted Macrocyclic Indole Derivatives." The first patent relates to macrocyclic indole derivatives of a specific general formula, detailing methods of preparation, intermediate compounds, and pharmaceutical compositions. These compounds are particularly useful for the treatment or prophylaxis of hyperproliferative disorders, either as a sole agent or in combination with other active ingredients. The second patent similarly focuses on substituted macrocyclic indole derivatives, emphasizing their preparation methods and applications in pharmaceutical compositions for treating diseases.

Career Highlights

Throughout his career, Fitzgerald has worked with notable companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His work in these organizations has allowed him to develop innovative solutions and contribute to advancements in pharmaceutical research.

Collaborations

Fitzgerald has collaborated with several professionals in his field, including Sarah Anna Liesa Johannes and Philipp Buchgraber. These collaborations have further enriched his research and development efforts.

Conclusion

Mark A Fitzgerald stands out as a key figure in the realm of pharmaceutical innovations, with a focus on macrocyclic indole derivatives. His contributions have the potential to impact the treatment of various diseases significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…